Evaluation of a Live Attenuated Human Metapneumovirus Vaccine in Adults and Children

Authors:

Abstract
We conducted a phase I clinical trial of an experimental live attenuated recombinant human metapneumovirus (HMPV) vaccine (rHMPV-Pa) sequentially in adults, HMPV-seropositive children, and HMPV-seronegative children, the target population for vaccination. rHMPV-Pa was appropriately restricted in replication in adults and HMPV-seropositive children but was overattenuated for HMPV-seronegative children.
Funding Information
  • National Institute of Allergy and Infectious Diseases

This publication has 16 references indexed in Scilit: